← 產業報告目錄
Drug Containment Solution Industry Research Report 2026
出版商 APO Research產業別 Software & IT Services出版日期 2026-07-04頁數 116報告編號 APO-305ed70601
授權報價
| Single User | $2,950 USD |
| Multi User | $4,430 USD |
| Enterprise | $5,900 USD |
報告摘要
The global Drug Containment Solution market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Drug Containment Solution market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Drug Containment Solution market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Drug Containment Solution market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Drug Containment Solution include Stevanato Group, BD, AptarGroup, Hergesheimer AG, Catalent, Inc., West Pharmaceutical Services, Inc., Schott AG, Stearate Group and NIPRO, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Drug Containment Solution market in terms of revenue (US$ million) and, where applicable, service volume (k units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Drug Containment Solution.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Drug Containment Solution Market by Company
Stevanato Group
BD
AptarGroup
Hergesheimer AG
Catalent, Inc.
West Pharmaceutical Services, Inc.
Schott AG
Stearate Group
NIPRO
Owen Mumford Limited
Psalmed AG
Drug Containment Solution Segment by Type
Vials
Ampoules
Bottles
Drug Containment Solution Segment by Application
Hospitals
Clinics
Home Care Settings
Ambulatory Surgical Centers
Drug Containment Solution Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Drug Containment Solution market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Drug Containment Solution and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Drug Containment Solution.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Drug Containment Solution companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
目錄 Table of Contents
1 Preface
1.1 Scope of Report
1.2 Reasons for Doing This Study
1.3 Research Methodology
1.4 Research Process
1.5 Data Source
1.5.1 Secondary Sources
1.5.2 Primary Sources
2 Market Overview
2.1 Product Definition
2.2 Drug Containment Solution by Type
2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
2.2.2 Vials
2.2.3 Ampoules
2.2.4 Bottles
2.3 Drug Containment Solution by Application
2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
2.3.2 Hospitals
2.3.3 Clinics
2.3.4 Home Care Settings
2.3.5 Ambulatory Surgical Centers
2.4 Assumptions and Limitations
3 Drug Containment Solution Breakdown Data by Type
3.1 Global Drug Containment Solution Historic Market Size by Type (2021-2026)
3.2 Global Drug Containment Solution Forecasted Market Size by Type (2027-2032)
4 Drug Containment Solution Breakdown Data by Application
4.1 Global Drug Containment Solution Historic Market Size by Application (2021-2026)
4.2 Global Drug Containment Solution Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
5.1 Global Drug Containment Solution Market Perspective (2021-2032)
5.2 Global Drug Containment Solution Growth Trends by Region
5.2.1 Global Drug Containment Solution Market Size by Region: 2021 VS 2025 VS 2032
5.2.2 Drug Containment Solution Historic Market Size by Region (2021-2026)
5.2.3 Drug Containment Solution Forecasted Market Size by Region (2027-2032)
5.3 Drug Containment Solution Market Dynamics
5.3.1 Drug Containment Solution Industry Trends
5.3.2 Drug Containment Solution Market Drivers
5.3.3 Drug Containment Solution Market Challenges
5.3.4 Drug Containment Solution Market Restraints
6 Market Competitive Landscape by Players
6.1 Global Top Drug Containment Solution Players by Revenue
6.1.1 Global Top Drug Containment Solution Players by Revenue (2021-2026)
6.1.2 Global Drug Containment Solution Revenue Market Share by Players (2021-2026)
6.2 Global Drug Containment Solution Industry Players Ranking, 2023 VS 2024 VS 2025
6.3 Global Key Players of Drug Containment Solution Head Office and Area Served
6.4 Global Drug Containment Solution Players, Product Type & Application
6.5 Global Drug Containment Solution Manufacturers Established Date
6.6 Global Drug Containment Solution Market CR5 and HHI
6.7 Global Players Mergers & Acquisition
7 North America
7.1 North America Drug Containment Solution Market Size (2021-2032)
7.2 North America Drug Containment Solution Market Growth Rate by Country: 2021 VS 2025 VS 2032
7.3 North America Drug Containment Solution Market Size by Country (2021-2026)
7.4 North America Drug Containment Solution Market Size by Country (2027-2032)
7.5 United States
7.5 United States
7.6 Canada
7.7 Mexico
8 Europe
8.1 Europe Drug Containment Solution Market Size (2021-2032)
8.2 Europe Drug Containment Solution Market Growth Rate by Country: 2021 VS 2025 VS 2032
8.3 Europe Drug Containment Solution Market Size by Country (2021-2026)
8.4 Europe Drug Containment Solution Market Size by Country (2027-2032)
8.5 Germany
8.6 France
8.7 U.K.
8.8 Italy
8.9 Spain
8.10 Russia
8.11 Netherlands
8.12 Nordic Countries
9 Asia-Pacific
9.1 Asia-Pacific Drug Containment Solution Market Size (2021-2032)
9.2 Asia-Pacific Drug Containment Solution Market Growth Rate by Country: 2021 VS 2025 VS 2032
9.3 Asia-Pacific Drug Containment Solution Market Size by Country (2021-2026)
9.4 Asia-Pacific Drug Containment Solution Market Size by Country (2027-2032)
9.5 China
9.6 Japan
9.7 South Korea
9.8 India
9.9 Australia
9.10 China Taiwan
9.11 Southeast Asia
10 South America
10.1 South America Drug Containment Solution Market Size (2021-2032)
10.2 South America Drug Containment Solution Market Growth Rate by Country: 2021 VS 2025 VS 2032
10.3 South America Drug Containment Solution Market Size by Country (2021-2026)
10.4 South America Drug Containment Solution Market Size by Country (2027-2032)
10.5 Brazil
10.6 Argentina
10.7 Chile
10.8 Colombia
10.9 Peru
11 Middle East & Africa
11.1 Middle East & Africa Drug Containment Solution Market Size (2021-2032)
11.2 Middle East & Africa Drug Containment Solution Market Growth Rate by Country: 2021 VS 2025 VS 2032
11.3 Middle East & Africa Drug Containment Solution Market Size by Country (2021-2026)
11.4 Middle East & Africa Drug Containment Solution Market Size by Country (2027-2032)
11.5 Saudi Arabia
11.6 Israel
11.7 United Arab Emirates
11.8 Turkey
11.9 Iran
11.10 Egypt
12 Players Profiled
12.1 Stevanato Group
12.1.1 Stevanato Group Company Information
12.1.2 Stevanato Group Business Overview
12.1.3 Stevanato Group Revenue in Drug Containment Solution Business (2021-2026)
12.1.4 Stevanato Group Drug Containment Solution Product Portfolio
12.1.5 Stevanato Group Recent Developments
12.2 BD
12.2.1 BD Company Information
12.2.2 BD Business Overview
12.2.3 BD Revenue in Drug Containment Solution Business (2021-2026)
12.2.4 BD Drug Containment Solution Product Portfolio
12.2.5 BD Recent Developments
12.3 AptarGroup
12.3.1 AptarGroup Company Information
12.3.2 AptarGroup Business Overview
12.3.3 AptarGroup Revenue in Drug Containment Solution Business (2021-2026)
12.3.4 AptarGroup Drug Containment Solution Product Portfolio
12.3.5 AptarGroup Recent Developments
12.4 Hergesheimer AG
12.4.1 Hergesheimer AG Company Information
12.4.2 Hergesheimer AG Business Overview
12.4.3 Hergesheimer AG Revenue in Drug Containment Solution Business (2021-2026)
12.4.4 Hergesheimer AG Drug Containment Solution Product Portfolio
12.4.5 Hergesheimer AG Recent Developments
12.5 Catalent, Inc.
12.5.1 Catalent, Inc. Company Information
12.5.2 Catalent, Inc. Business Overview
12.5.3 Catalent, Inc. Revenue in Drug Containment Solution Business (2021-2026)
12.5.4 Catalent, Inc. Drug Containment Solution Product Portfolio
12.5.5 Catalent, Inc. Recent Developments
12.6 West Pharmaceutical Services, Inc.
12.6.1 West Pharmaceutical Services, Inc. Company Information
12.6.2 West Pharmaceutical Services, Inc. Business Overview
12.6.3 West Pharmaceutical Services, Inc. Revenue in Drug Containment Solution Business (2021-2026)
12.6.4 West Pharmaceutical Services, Inc. Drug Containment Solution Product Portfolio
12.6.5 West Pharmaceutical Services, Inc. Recent Developments
12.7 Schott AG
12.7.1 Schott AG Company Information
12.7.2 Schott AG Business Overview
12.7.3 Schott AG Revenue in Drug Containment Solution Business (2021-2026)
12.7.4 Schott AG Drug Containment Solution Product Portfolio
12.7.5 Schott AG Recent Developments
12.8 Stearate Group
12.8.1 Stearate Group Company Information
12.8.2 Stearate Group Business Overview
12.8.3 Stearate Group Revenue in Drug Containment Solution Business (2021-2026)
12.8.4 Stearate Group Drug Containment Solution Product Portfolio
12.8.5 Stearate Group Recent Developments
12.9 NIPRO
12.9.1 NIPRO Company Information
12.9.2 NIPRO Business Overview
12.9.3 NIPRO Revenue in Drug Containment Solution Business (2021-2026)
12.9.4 NIPRO Drug Containment Solution Product Portfolio
12.9.5 NIPRO Recent Developments
12.10 Owen Mumford Limited
12.10.1 Owen Mumford Limited Company Information
12.10.2 Owen Mumford Limited Business Overview
12.10.3 Owen Mumford Limited Revenue in Drug Containment Solution Business (2021-2026)
12.10.4 Owen Mumford Limited Drug Containment Solution Product Portfolio
12.10.5 Owen Mumford Limited Recent Developments
12.11 Psalmed AG
12.11.1 Psalmed AG Company Information
12.11.2 Psalmed AG Business Overview
12.11.3 Psalmed AG Revenue in Drug Containment Solution Business (2021-2026)
12.11.4 Psalmed AG Drug Containment Solution Product Portfolio
12.11.5 Psalmed AG Recent Developments
13 Report Conclusion
14 Disclaimer
圖表清單 List of Tables & Figures
List of Tables
Table 1. Secondary Sources
Table 2. Primary Sources
Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million)
Table 5. Global Drug Containment Solution Market Size by Type (2021-2026) & (US$ Million)
Table 6. Global Drug Containment Solution Revenue Market Share by Type (2021-2026)
Table 7. Global Drug Containment Solution Forecasted Market Size by Type (2027-2032) & (US$ Million)
Table 8. Global Drug Containment Solution Revenue Market Share by Type (2027-2032)
Table 9. Global Drug Containment Solution Market Size by Application (2021-2026) & (US$ Million)
Table 10. Global Drug Containment Solution Revenue Market Share by Application (2021-2026)
Table 11. Global Drug Containment Solution Forecasted Market Size by Application (2027-2032) & (US$ Million)
Table 12. Global Drug Containment Solution Revenue Market Share by Application (2027-2032)
Table 13. Global Drug Containment Solution Market Size by Region (US$ Million): 2021 VS 2025 VS 2032
Table 14. Global Drug Containment Solution Market Size by Region (2021-2026) & (US$ Million)
Table 15. Global Drug Containment Solution Market Share by Region (2021-2026)
Table 16. Global Drug Containment Solution Forecasted Market Size by Region (2027-2032) & (US$ Million)
Table 17. Global Drug Containment Solution Market Share by Region (2027-2032)
Table 18. Drug Containment Solution Industry Trends
Table 19. Drug Containment Solution Industry Drivers
Table 20. Drug Containment Solution Industry Opportunities and Challenges
Table 21. Drug Containment Solution Market Restraints
Table 22. Global Top Drug Containment Solution Players by Revenue (US$ Million) & (2021-2026)
Table 23. Global Drug Containment Solution Revenue Market Share by Players (2021-2026)
Table 24. Global Drug Containment Solution Industry Players Ranking, 2024 VS 2025 VS 2026
Table 25. Global Key Players of Drug Containment Solution, Headquarters and Area Served
Table 26. Global Drug Containment Solution Players, Product Type & Application
Table 27. Global Players Market Concentration Ratio (CR5 and HHI)
Table 28. Global Drug Containment Solution by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025)
Table 29. Players Mergers & Acquisitions, Expansion Plans
Table 30. North America Drug Containment Solution Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 31. North America Drug Containment Solution Market Size by Country (2021-2026) & (US$ Million)
Table 32. North America Drug Containment Solution Market Size by Country (2027-2032) & (US$ Million)
Table 33. Europe Drug Containment Solution Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 34. Europe Drug Containment Solution Market Size by Country (2021-2026) & (US$ Million)
Table 35. Europe Drug Containment Solution Market Size by Country (2027-2032) & (US$ Million)
Table 36. Asia Pacific Drug Containment Solution Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 37. Asia Pacific Drug Containment Solution Market Size by Region (2021-2026) & (US$ Million)
Table 38. Asia Pacific Drug Containment Solution Market Size by Country (2027-2032) & (US$ Million)
Table 39. South America Drug Containment Solution Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 40. South America Drug Containment Solution Market Size by Country (2021-2026) & (US$ Million)
Table 41. South America Drug Containment Solution Market Size by Country (2027-2032) & (US$ Million)
Table 42. Middle East & Africa Drug Containment Solution Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 43. Middle East & Africa Drug Containment Solution Market Size by Country (2021-2026) & (US$ Million)
Table 44. Middle East & Africa Drug Containment Solution Market Size by Country (2027-2032) & (US$ Million)
Table 45. Stevanato Group Company Information
Table 46. Stevanato Group Business Overview
Table 47. Stevanato Group Revenue in Drug Containment Solution Business (2021-2026) & (US$ Million)
Table 48. Stevanato Group Drug Containment Solution Product Portfolio
Table 49. Stevanato Group Recent Developments
Table 50. BD Company Information
Table 51. BD Business Overview
Table 52. BD Revenue in Drug Containment Solution Business (2021-2026) & (US$ Million)
Table 53. BD Drug Containment Solution Product Portfolio
Table 54. BD Recent Developments
Table 55. AptarGroup Company Information
Table 56. AptarGroup Business Overview
Table 57. AptarGroup Revenue in Drug Containment Solution Business (2021-2026) & (US$ Million)
Table 58. AptarGroup Drug Containment Solution Product Portfolio
Table 59. AptarGroup Recent Developments
Table 60. Hergesheimer AG Company Information
Table 61. Hergesheimer AG Business Overview
Table 62. Hergesheimer AG Revenue in Drug Containment Solution Business (2021-2026) & (US$ Million)
Table 63. Hergesheimer AG Drug Containment Solution Product Portfolio
Table 64. Hergesheimer AG Recent Developments
Table 65. Catalent, Inc. Company Information
Table 66. Catalent, Inc. Business Overview
Table 67. Catalent, Inc. Revenue in Drug Containment Solution Business (2021-2026) & (US$ Million)
Table 68. Catalent, Inc. Drug Containment Solution Product Portfolio
Table 69. Catalent, Inc. Recent Developments
Table 70. West Pharmaceutical Services, Inc. Company Information
Table 71. West Pharmaceutical Services, Inc. Business Overview
Table 72. West Pharmaceutical Services, Inc. Revenue in Drug Containment Solution Business (2021-2026) & (US$ Million)
Table 73. West Pharmaceutical Services, Inc. Drug Containment Solution Product Portfolio
Table 74. West Pharmaceutical Services, Inc. Recent Developments
Table 75. Schott AG Company Information
Table 76. Schott AG Business Overview
Table 77. Schott AG Revenue in Drug Containment Solution Business (2021-2026) & (US$ Million)
Table 78. Schott AG Drug Containment Solution Product Portfolio
Table 79. Schott AG Recent Developments
Table 80. Stearate Group Company Information
Table 81. Stearate Group Business Overview
Table 82. Stearate Group Revenue in Drug Containment Solution Business (2021-2026) & (US$ Million)
Table 83. Stearate Group Drug Containment Solution Product Portfolio
Table 84. Stearate Group Recent Developments
Table 85. NIPRO Company Information
Table 86. NIPRO Business Overview
Table 87. NIPRO Revenue in Drug Containment Solution Business (2021-2026) & (US$ Million)
Table 88. NIPRO Drug Containment Solution Product Portfolio
Table 89. NIPRO Recent Developments
Table 90. Owen Mumford Limited Company Information
Table 91. Owen Mumford Limited Business Overview
Table 92. Owen Mumford Limited Revenue in Drug Containment Solution Business (2021-2026) & (US$ Million)
Table 93. Owen Mumford Limited Drug Containment Solution Product Portfolio
Table 94. Owen Mumford Limited Recent Developments
Table 95. Psalmed AG Company Information
Table 96. Psalmed AG Business Overview
Table 97. Psalmed AG Revenue in Drug Containment Solution Business (2021-2026) & (US$ Million)
Table 98. Psalmed AG Drug Containment Solution Product Portfolio
Table 99. Psalmed AG Recent Developments
Table 100. Authors List of This Report
List of Figures
Figure 1. Research Methodology
Figure 2. Research Process
Figure 3. Key Executives Interviewed
Figure 4. Drug Containment Solution Product Image
Figure 5. Global Drug Containment Solution Market Size Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
Figure 6. Global Drug Containment Solution Market Share by Type: 2025 VS 2032
Figure 7. Vials Product
Figure 8. Ampoules Product
Figure 9. Bottles Product
Figure 10. Global Drug Containment Solution Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million)
Figure 11. Global Drug Containment Solution Market Share by Application: 2025 VS 2032
Figure 12. Hospitals Product
Figure 13. Clinics Product
Figure 14. Home Care Settings Product
Figure 15. Ambulatory Surgical Centers Product
Figure 16. Global Drug Containment Solution Market Size (US$ Million), Year-over-Year: 2021-2032
Figure 17. Global Drug Containment Solution Market Size, (US$ Million), 2021 VS 2025 VS 2032
Figure 18. Global Drug Containment Solution Market Share by Region: 2025 VS 2032
Figure 19. Global Drug Containment Solution Market Share by Players in 2025
Figure 20. Global Drug Containment Solution Manufacturers Established Date
Figure 21. Global Top 5 and 10 Drug Containment Solution Players Market Share by Revenue in 2025
Figure 22. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025
Figure 23. North America Drug Containment Solution Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 24. North America Drug Containment Solution Market Share by Country (2021-2032)
Figure 25. United States Drug Containment Solution Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 26. Canada Drug Containment Solution Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 27. Mexico Drug Containment Solution Market Share by Country (2021-2032)
Figure 28. Europe Drug Containment Solution Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 29. Europe Drug Containment Solution Market Share by Country (2021-2032)
Figure 30. Germany Drug Containment Solution Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 31. France Drug Containment Solution Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 32. U.K. Drug Containment Solution Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 33. Italy Drug Containment Solution Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 34. Spain Drug Containment Solution Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 35. Russia Drug Containment Solution Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 36. Netherlands Drug Containment Solution Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 37. Nordic Countries Drug Containment Solution Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 38. Asia-Pacific Drug Containment Solution Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 39. Asia-Pacific Drug Containment Solution Market Share by Country (2021-2032)
Figure 40. China Drug Containment Solution Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 41. Japan Drug Containment Solution Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 42. South Korea Drug Containment Solution Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 43. India Drug Containment Solution Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 44. India Drug Containment Solution Market Share by Country (2021-2032)
Figure 45. Australia Drug Containment Solution Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 46. China Taiwan Drug Containment Solution Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 47. Southeast Asia Drug Containment Solution Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 48. South America Drug Containment Solution Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 49. South America Drug Containment Solution Market Share by Country (2021-2032)
Figure 50. Brazil Drug Containment Solution Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 51. Argentina Drug Containment Solution Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 52. Chile Drug Containment Solution Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 53. Colombia Drug Containment Solution Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 54. Peru Drug Containment Solution Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 55. Stevanato Group Revenue Growth Rate in Drug Containment Solution Business (2021-2026)
Figure 56. BD Revenue Growth Rate in Drug Containment Solution Business (2021-2026)
Figure 57. AptarGroup Revenue Growth Rate in Drug Containment Solution Business (2021-2026)
Figure 58. Hergesheimer AG Revenue Growth Rate in Drug Containment Solution Business (2021-2026)
Figure 59. Catalent, Inc. Revenue Growth Rate in Drug Containment Solution Business (2021-2026)
Figure 60. West Pharmaceutical Services, Inc. Revenue Growth Rate in Drug Containment Solution Business (2021-2026)
Figure 61. Schott AG Revenue Growth Rate in Drug Containment Solution Business (2021-2026)
Figure 62. Stearate Group Revenue Growth Rate in Drug Containment Solution Business (2021-2026)
Figure 63. NIPRO Revenue Growth Rate in Drug Containment Solution Business (2021-2026)
Figure 64. Owen Mumford Limited Revenue Growth Rate in Drug Containment Solution Business (2021-2026)
Figure 65. Psalmed AG Revenue Growth Rate in Drug Containment Solution Business (2021-2026)
提及公司
Stevanato GroupBDAptarGroupHergesheimer AGCatalent, Inc.West Pharmaceutical Services, Inc.Schott AGStearate GroupNIPROOwen Mumford LimitedPsalmed AG
量子訊息有限公司為 APO Research 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們